AtheroGenics Announced Dismissal of Class Action Litigation

All securities class action lawsuits filed against AtheroGenics, Inc. and certain of its officers and directors, has been dismissed as announced by the company.

The lawsuits had been consolidated and recently transferred to federal court in Georgia. The plaintiffs agreed to dismiss the matters voluntarily, without prejudice, and without any payment or consideration to the plaintiffs or their counsel.

Link [www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/260785]

Related?

Leave a Reply


Protected by Comment Guard Pro